Harbor Investment Advisory, LLC Astrazeneca PLC Transaction History
Harbor Investment Advisory, LLC
- $1.22 Billion
- Q1 2025
A detailed history of Harbor Investment Advisory, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 3,033 shares of AZN stock, worth $222,925. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,033
Previous 2,665
13.81%
Holding current value
$222,925
Previous $174,000
27.59%
% of portfolio
0.02%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,364Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.01 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.43 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...